Correlation Between Sabra Health and CEOTRONICS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sabra Health and CEOTRONICS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sabra Health and CEOTRONICS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sabra Health Care and CEOTRONICS, you can compare the effects of market volatilities on Sabra Health and CEOTRONICS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sabra Health with a short position of CEOTRONICS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sabra Health and CEOTRONICS.

Diversification Opportunities for Sabra Health and CEOTRONICS

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Sabra and CEOTRONICS is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Sabra Health Care and CEOTRONICS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CEOTRONICS and Sabra Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sabra Health Care are associated (or correlated) with CEOTRONICS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CEOTRONICS has no effect on the direction of Sabra Health i.e., Sabra Health and CEOTRONICS go up and down completely randomly.

Pair Corralation between Sabra Health and CEOTRONICS

Assuming the 90 days horizon Sabra Health Care is expected to under-perform the CEOTRONICS. But the stock apears to be less risky and, when comparing its historical volatility, Sabra Health Care is 1.96 times less risky than CEOTRONICS. The stock trades about -0.05 of its potential returns per unit of risk. The CEOTRONICS is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  501.00  in CEOTRONICS on September 24, 2024 and sell it today you would earn a total of  69.00  from holding CEOTRONICS or generate 13.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sabra Health Care  vs.  CEOTRONICS

 Performance 
       Timeline  
Sabra Health Care 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sabra Health Care has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Sabra Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
CEOTRONICS 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in CEOTRONICS are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, CEOTRONICS unveiled solid returns over the last few months and may actually be approaching a breakup point.

Sabra Health and CEOTRONICS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sabra Health and CEOTRONICS

The main advantage of trading using opposite Sabra Health and CEOTRONICS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sabra Health position performs unexpectedly, CEOTRONICS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CEOTRONICS will offset losses from the drop in CEOTRONICS's long position.
The idea behind Sabra Health Care and CEOTRONICS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum